BRCA1 and cancer: The role of mTOR in sustaining HSP90 and BRCA-1 expression level in stressed cancer cells was demonstrated in this setting by using NVB-BEZ-235, dual mTOR inhibitor that strongly downregulated both proteins (Fig. 5C).